Skip To Main Content
Ivana Baranová on Muck Rack

Ivana Baranová

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ivana

Contact Ivana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cell line-specific modulation of colorectal cancer cell behavior following SGLT2 inhibition via empagliflozin

|
By Ivana Baranová, Katarina Dibdiakova, Radovan Murín, Marek Samec, Roman Eibner, Angel Cid-Arregui
| Nature Verified
Abstract Colorectal cancer (CRC) is a major global health problem, with type 2 diabetes mellitus (T2DM) and obesity among its significant risk factors. Empagliflozin (EMPA), a selective sodium–glucose cotransporter 2 (SGLT2) inhibitor widely used in the treatment of T2DM, has also demonstrated potential anticancer effects. However, reports of possible adverse effects in certain oncological contexts have raised concerns.
Open in Who Shared Issue with article?
See all 1 articles